Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.
Neuromyelitis optica: atypical clinical and neuroradiological presentation.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity.
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
Characterisation of uveitis in association with multiple sclerosis.
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
2015 Multiple Sclerosis Experts Summit.
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis.
Burden and quality of life in caregivers of persons with multiple sclerosis.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
Pages
« first
‹ previous
…
290
291
292
293
294
295
296
297
298
…
next ›
last »